![]()
|
|
||||||||
J. Biol. Chem., Vol. 280, Issue 4, 2857-2862, January 28, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



||
From the
Department of Biomolecular Sciences, University of Manchester Institute of Science and Technology, P. O. Box 88, Manchester M60 1QD, United Kingdom,
Department of Clinical Laboratory Sciences, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, United Kingdom, and ¶MRC Clinical Sciences Centre, Faculty of Medicine, Imperial College, Hammersmith Hospital Campus, Du Cane Road, London, W12 0NN, United Kingdom
Multidrug resistance of cancer cells and pathogens is a serious clinical problem. A major factor contributing to drug resistance in cancer is the over-expression of P-glycoprotein, a plasma membrane ATP-binding cassette (ABC) drug efflux pump. Three-dimensional structural data with a resolution limit of
8 Å have been obtained from two-dimensional crystals of P-glycoprotein trapped in the nucleotide-bound state. Each of the two transmembrane domains of P-glycoprotein consists of six long
-helical segments. Five of the
-helices from each transmembrane domain are related by a pseudo-2-fold symmetry, whereas the sixth breaks the symmetry. The two
-helices positioned closest to the (pseudo-) symmetry axis at the center of the molecule appear to be kinked. A large loop of density at the extracellular surface of the transporter is likely to correspond to the glycosylated first extracellular loop, whereas two globular densities at the cytoplasmic side correspond to the hydrophilic, nucleotide-binding domains. This is the first three-dimensional structure for an intact eukaryotic ABC transporter. Comparison with the structures of two prokaryotic ABC transporters suggests significant differences in the packing of the transmembrane
-helices within this protein family.
Received for publication, September 8, 2004 , and in revised form, October 12, 2004.
* This work was supported by Cancer Research UK, a European Molecular Biology Organization short-term fellowship (to M. F. R.), and the Medical Research Council, UK. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
|| To whom correspondence should be addressed: Dept. of Biomolecular Sciences, University of Manchester Institute of Science and Technology, P. O. Box 88, Manchester M60 1QD, UK. Tel.: 44-1612004187; Fax: 44-1612360409; E-mail: r.ford{at}umist.ac.uk.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
P. D. W. Eckford and F. J. Sharom Functional Characterization of Escherichia coli MsbA: INTERACTION WITH NUCLEOTIDES AND SUBSTRATES J. Biol. Chem., May 9, 2008; 283(19): 12840 - 12850. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Y. Lee, I. L. Urbatsch, A. E. Senior, and S. Wilkens Nucleotide-induced Structural Changes in P-glycoprotein Observed by Electron Microscopy J. Biol. Chem., February 29, 2008; 283(9): 5769 - 5779. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Matsson, G. Englund, G. Ahlin, C. A. S. Bergstrom, U. Norinder, and P. Artursson A Global Drug Inhibition Pattern for the Human ATP-Binding Cassette Transporter Breast Cancer Resistance Protein (ABCG2) J. Pharmacol. Exp. Ther., October 1, 2007; 323(1): 19 - 30. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Gavigan, M. Shen, S. G. Machado, and A. Bell Influence of the Plasmodium falciparum P-glycoprotein homologue 1 (pfmdr1 gene product) on the antimalarial action of cyclosporin J. Antimicrob. Chemother., February 1, 2007; 59(2): 197 - 203. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. E. Sauna and S. V. Ambudkar About a switch: how P-glycoprotein (ABCB1) harnesses the energy of ATP binding and hydrolysis to do mechanical work Mol. Cancer Ther., January 1, 2007; 6(1): 13 - 23. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Sarkadi, L. Homolya, G. Szakacs, and A. Varadi Human Multidrug Resistance ABCB and ABCG Transporters: Participation in a Chemoimmunity Defense System. Physiol Rev, October 1, 2006; 86(4): 1179 - 1236. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Y. Haubertin, H. Madaoui, A. Sanson, R. Guerois, and S. Orlowski Molecular Dynamics Simulations of E. coli MsbA Transmembrane Domain: Formation of a Semipore Structure Biophys. J., October 1, 2006; 91(7): 2517 - 2531. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Deeley, C. Westlake, and S. P. C. Cole Transmembrane Transport of Endo- and Xenobiotics by Mammalian ATP-Binding Cassette Multidrug Resistance Proteins. Physiol Rev, July 1, 2006; 86(3): 849 - 899. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Aller and V. M. Unger Projection structure of the human copper transporter CTR1 at 6-A resolution reveals a compact trimer with a novel channel-like architecture PNAS, March 7, 2006; 103(10): 3627 - 3632. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Dalmas, C. Orelle, A.-E. Foucher, C. Geourjon, S. Crouzy, A. Di Pietro, and J.-M. Jault The Q-loop Disengages from the First Intracellular Loop during the Catalytic Cycle of the Multidrug ABC Transporter BmrA J. Biol. Chem., November 4, 2005; 280(44): 36857 - 36864. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Reyes and G. Chang Structure of the ABC Transporter MsbA in Complex with ADP{middle dot}Vanadate and Lipopolysaccharide Science, May 13, 2005; 308(5724): 1028 - 1031. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |